Envision: Science Innovates
Where innovation, collaboration and growth converge
Themes include
Knowledge Economies on the Global Stage
Innovation is vital for economic growth and real estate demand. The private and public sectors must adapt to demographic shifts, changing property requirements, and new technologies. Occupiers and investors need to diversify their portfolios to accommodate skilled talent and innovation-driven growth. Co-locating institutions, corporates, talent, and infrastructure is key, with a focus on submarket and micromarket performance. Understanding pricing sensitivities is crucial for tenants and owners to maximize returns. Public authorities, corporate occupiers, and real estate investors should collaborate for integrated, sustainable approaches to innovation-led regeneration.
Raising capital in UK biotech
Availability and access to capital is fundamental to the creation and growth of the UK Biotech industry. The UK listed markets continue to challenge the supremacy of the Nasdaq in the US, with the announcement of the Mansion House Compact setting a course for the UK to unlock significant capital directly from listed equity funds to benefit the growth of innovative companies. Against this backdrop of the financial markets in the private and public sector, this panel will focus on the immediate outlook for raising capital for the UK, identifying challenges and opportunities companies are facing to facilitate growth.
Policy to Execution…Partnerships and Collaboration
Partnerships between the public and private sector are fundamental to unlocking the full potential of the life sciences sector. A successful partnership can be measured across economic, financial and social objectives, but how does the weighting of this criteria shift in the eyes of the beholder? This session will explore how partnership can come in many forms, be that directly with central government or local authorities, academic and research institutions partnering with the private sector to enable efficacy in their operational estate, or operators of space partnering with big pharma and start-up businesses to enable scientific breakthroughs.
Event Agenda
Welcome reception and breakfast
Opening remarks
Panellists include:
Chris Walters
Chris is Head of UK Life Sciences at JLL focusing on the science, technology and innovation sector. Through experience working with NHS Trusts; academic and research institutions; local authorities; and a diverse set of private sector clients; Chris is recognised as an industry-leading expert on both the UK and European markets.
Fireside chat: View from across the pond
Chris Walters, Head of UK Life Sciences at JLL will chair a fireside chat between Travis McCready, Chair – Global Life Sciences Advisory Board at JLL and Beth Thompson, Chief Strategy Officer, Wellcome Trust discussing:
- The growth of urban clusters,
- The role of AI and how it will impact the sector
- The role of public sector policy
Panellists include:
Travis McCready
Travis McCready is the head of life sciences markets in the Americas for JLL with over 25 years of experience leading public, private, and non-profit ventures. Travis is the former President & CEO of the $1.6 billion life sciences funding agency Massachusetts Life Sciences Centre.
Dr. Beth Thompson
Dr Beth Thompson is Wellcome’s Chief Strategy Officer, responsible for the the strategy and programme office, government relations and strategic partnerships, policy, and transition and legacy teams. In 2017 Beth was awarded an MBE for services to science for successfully advocating against amendments to the EU General Data Protection Regulation.
Innovation Geographies
The Innovation Geographies report highlights the importance of innovation as a driving force for economic growth and real estate demand. Key findings emphasize the need for diversification, co-location, pricing sensitivity, and proactive collaboration to harness the benefits of innovation-led growth.
Break
Raising capital in UK Biotech
Availability and access to capital is fundamental to the creation and growth of the UK Biotech industry. The UK listed markets continue to challenge the supremacy of the Nasdaq in the US, with the announcement of the Mansion House Compact setting a course for the UK to unlock significant capital directly from listed equity funds to benefit the growth of innovative companies.
Against this backdrop of the financial markets in the private and public sector, this panel will focus on the immediate outlook for raising capital for the UK, identifying challenges and opportunities companies are facing to facilitate growth.
Panellists include:
Jason Mellad
Jason is CEO and co-founder of Start Codon, a Cambridge based venture builder, which aims to identify the most disruptive healthcare founders and innovations worldwide, seed fund them and leverage the exceptional resources of the Cambridge cluster to de-risk and drive the success of their start-ups.
Michael Cunniffe
Partnership & collaboration
Partnerships between the public and private sector are fundamental to unlocking the full potential of the life sciences sector. A successful partnership can be measured across economic, financial and social objectives, but how does the weighting of this criteria shift in the eyes of the beholder?
This session will explore how partnership can come in many forms, be that directly with central government or local authorities, academic and research institutions partnering with the private sector to enable efficacy in their operational estate, or operators of space partnering with big pharma and start-up businesses to enable scientific breakthroughs.
Panellists include:
Katherine Rodgers
Katherine is Director of Property Development at the University of Cambridge, leading the Property Group responsible for the development of the University’s estate. This includes a variety of commercial and residential developments including West and North West Cambridge, the University’s solar farm and the teaching, learning and research space.
Dr Suki Balendra
Dr Stephen Mayhew
Stephen joined the Francis Crick Institute in 2023 as Chief Business Officer. Stephen brings over 20 years of experience in life sciences research and development organisations spanning academia, biotech and global big pharma, with extensive expertise in strategic and portfolio management, business development, partnerships and collaborations.
Matthew Weiner
Matthew is Head of Regeneration Partnerships at The Crown Estate working on their regional strategy. Matthew leads on TCE’s science and innovation strategy focusing on the Crown’s existing 20-acre holding at Cambridge Business Park but also on the recently announced tripartite partnership with Oxford Science Enterprises and Pioneer Group.
Closing remarks
Pave the way for new discoveries
Our expert life sciences team unlock limitless possibilities through tailored real estate solutions.
PRIVACY NOTICE
Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.
Generally the personal information we collect from you are for the purposes of dealing with your enquiry.
We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.